The arrest warrant for Jang Won-jun, former CEO of Shin Poong Pharmaceutical, is dismissed

Reporter Paul Lee / approved : 2023-01-29 23:55:26
  • -
  • +
  • 인쇄
This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology
(사진=연합뉴스)

[Alpha Biz=(Chicago) Reporter Paul Lee] An arrest warrant for former CEO of Shinpoong Pharmaceutical Co., who was accused of raising slush funds worth 5.7 billion won through false transactions with customers and inflating unit prices, was rejected by the court.

Kim Jung-min, a senior judge in charge of warrants at the Seoul Central District Court, on the 27th rejected the request for former CEO Jang Won-joon's arrest warrant filed by the prosecution on charges of violating the Act on External Audit of Stock Companies, saying, "It is hard to say that there is a fear of destroying evidence."

Former CEO Jang Won-joon is suspected of colluding with Executive Director A of Shinpoong Pharmaceutical to create a slush fund worth 5.7 billion won by returning the difference after a fake transaction with Company B, a pharmaceutical raw material company, from April 2011 to March 2018. It is also suspected of falsely preparing and disclosing Shinpoong Pharmaceutical's financial statements.

Meanwhile, executive director A was first put on trial under arrest last month, and former Shinpoong Pharmaceutical Chairman Jang Yong-taek, who was involved in the allegations, died and was treated as having no right to indict.

Alphabiz Reporter Paul Lee(hoondork@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years2025.11.07
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations2025.11.07
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom2025.11.07
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking2025.11.07
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사